Statins Could Be Used to Control Replication of Some Viruses, Including HIV-1
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Statins are mainly known for their plasma cholesterol-lowering properties and are widely used for the prevention of cardiovascular diseases. They however also exert pleiotropic effects through a variety of mechanisms, among which several immunosuppressive effects that are unrelated to their cholesterol-lowering activity. Interestingly, there has been recent evidence of antiviral effects, including preliminary studies on the efficacy of statins against HIV-1. This paper more particularly focuses on the specific inhibition of the binding of leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule (ICAM-1) by statins, independently of the inhibition of HMGCoA reductase. Targeting the statin-binding site within LFA-1 or regulating LFA-1 affinity by inhibiting prenylation of the small GTPases could prove useful to treat inflammatory, autoimmune diseases and possibly viral infections, including HIV-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
The discovery and development of HMG-CoA reductase inhibitors.
Endo, A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41379-3 · Cited by 847
Recruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions
McDonald, D., Wu, L., Bohks, S. M., KewalRamani, V. N., Unutmaz, D., & Hope, T. J. (2003) · Science · doi:10.1126/science.1084238 · Cited by 707 · cited 2×
“Immunological synapse between DCs and T cells is crucial for virus transmission (7,85,101), which is increased by co-stimulatory molecules such as ICAM-1 and LFA-1, as well as LFA-3 and CD2 (101,131,145).”
BackgroundA novel anti-inflammatory role for simvastatin in inflammatory arthritis.
Leung, B. P., Sattar, N., Crilly, A., Prach, M., McCarey, D. W., Payne, H., Madhok, R., Campbell, C., Gracie, J. A., Liew, F. Y., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1524 · Cited by 434
A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma.
McKay, A., Leung, B. P., McInnes, I. B., Thomson, N. C., & Liew, F. Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2903 · Cited by 309
Arrighi, J.-F., Pion, M., Garcia, E., Escola, J.-M., van Kooyk, Y., Geijtenbeek, T. B., & Piguet, V. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041356 · Cited by 240 · cited 1×
“Immunological synapse between DCs and T cells is crucial for virus transmission (7,85,101), which is increased by co-stimulatory molecules such as ICAM-1 and LFA-1, as well as LFA-3 and CD2 (101,131,145).”
BackgroundRole for Human Immunodeficiency Virus Type 1 Membrane Cholesterol in Viral Internalization
Guyader, M., Kiyokawa, E., Abrami, L., Turelli, P., & Trono, D. (2002) · Journal of Virology · doi:10.1128/jvi.76.20.10356-10364.2002 · Cited by 170 · cited 1×
“Even though the mechanism of membrane fusion still remains to be fully understood, the chol present in the viral envelope has been shown to play an important role in this process (62).”
BackgroundGhittoni, R., Patrussi, L., Pirozzi, K., Pellegrini, M., Lazzerini, P. E., Capecchi, P. L., Pasini, F. L., & Baldari, C. T. (2005) · The FASEB Journal · doi:10.1096/fj.04-2702fje · Cited by 154 · cited 2×
“The efficiency of these small GTPases can be controlled by isoprenylation, a mechanism that can be affected by statins (54).”
BackgroundVirion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity
Campbell, S. M., Crowe, S. M., & Mak, J. (2002) · AIDS · doi:10.1097/00002030-200211220-00004 · Cited by 139 · cited 1×
“Chol-dependent events have been identified as also playing a prominent role during later steps in HIV-1 life cycle such as assembly and budding as well as in the maintenance of virus morphology and infectivity (22).”
BackgroundThe safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk
Corsini, A. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1026132412074 · Cited by 82 · cited 1×
“Unlike their antiviral effects, pharmacokinetic interactions between statins and drugs used for HAART have been studied in great details (28,31,48,117).”
Background
Cited by
Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling
York, A. G., Williams, K. J., Argus, J. P., Zhou, Q. D., Brar, G., Vergnes, L., Gray, E. E., Zhen, A., Wu, N. C., Yamada, D. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.045 · Cited by 461
Discrimination between exosomes and HIV-1: Purification of both vesicles from cell-free supernatants
Cantin, R., Diou, J., Bélanger, D., Tremblay, A. M., & Gilbert, C. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.07.007 · Cited by 319
Self-citationSun, H., & Singh, N. (2009) · Clinical Infectious Diseases · doi:10.1086/597039 · Cited by 65
“HIV Lovastatin Inhibition of HIV replication Cholesterol reduction; prenylation inhibition; interference with LFA-1/ICAMs interaction [146, 147]”
BackgroundInfluentialWang, Y., Wang, Y., Ding, L., Ren, X., Wang, B., Wang, L., Zhao, S., Yue, X., Wu, Z., Li, C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111738 · Cited by 27
Metadata
- Authors
- Gilbert, C., Bergeron, M., Méthot, S., Giguère, J.-F., & Tremblay, M. J.
- Venue
- Viral Immunology
- Publisher
- SAGE Publications
- Published
- 2005-09
- Volume
- 18
- Issue
- 3
- Pages
- 474-489
- ISSN
- 0882-8245 (ISSN-L)
- 1557-8976
- OpenAlex
- W2020595428
- Cited by
- 47
- References
- 10
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.